OneTest for Cancer

OneTest for Cancer 20/20 GeneSystems, Inc. ("20/20") is working to reduce cancer mortality around the world through early detection.

OneTest™️ is an accurate, affordable accessible screening test designed to help you detect your cancer risk early for 20+ cancer types with an easy pain-free capillary collection kit available without a lab or Dr. visit. We develop and commercialize blood tests with machine learning algorithms to maximize test accuracy.

You’re not afraid of cancer. You’re afraid of finding it too late.Early detection can make a significant difference. Man...
09/04/2026

You’re not afraid of cancer. You’re afraid of finding it too late.

Early detection can make a significant difference. Many cancers may not cause noticeable symptoms in their early stages—and most have no routine screening available.

OneTest for Cancer is an affordable, at-home blood test that screens for signals associated with 20+ cancers, helping you take a more proactive approach to your health.

Don’t wait for symptoms. Take action today.

Learn more at https://onetestforcancer.com/

09/03/2026

Most people see their daily cup of joe as a tasty treat or a much-needed pick-me-up—or both—but coffee has plenty of health benefits, too.

Read the full story at the link in the comments.🔗

08/28/2026

Firefighters face unique occupational exposures that may increase their cancer risk. Regular screening can help support earlier awareness and better conversations with a healthcare provider.

OneTest for Cancer is an at-home blood test that screens for signals associated with 20+ cancer types from one sample.

Don’t live with the risk. Test for it.

Learn more: onetestforcancer.com

OneTest does not diagnose cancer or replace guideline-recommended screenings. Please consult your healthcare provider about your personal risk and screening options.

Multi-cancer early detection should not be a luxury—and it shouldn’t have to cost $600–$900.New technology is making mul...
08/21/2026

Multi-cancer early detection should not be a luxury—and it shouldn’t have to cost $600–$900.

New technology is making multi-cancer screening more affordable and accessible. OneTest combines multiple protein biomarkers with AI-powered analysis to improve accuracy compared with biomarker testing alone and may identify cancer-related patterns before symptoms appear.

At $199, OneTest for Cancer offers convenient at-home blood collection and is designed to screen for 20+ cancers, including many without routine screening options.

Learn more: https://onetestforcancer.com

OneTest does not diagnose cancer or replace guideline-recommended cancer screenings.

It was great to see Jimmy again at Fire-Rescue International 2026!Moments like this are a powerful reminder of why we lo...
08/13/2026

It was great to see Jimmy again at Fire-Rescue International 2026!

Moments like this are a powerful reminder of why we love what we do at OneTest — and why early cancer detection matters.

Firefighters dedicate their lives to protecting others while facing occupational exposures that can put their own health at risk. Jimmy’s story reminds us just how important it is to be proactive about cancer screening and take action early.

Seeing Jimmy Creech at FRI brought us back to what our work is really about: real people, real stories, and the opportunity to detect cancer earlier, when it can make a difference.

Thank you, Jimmy, for sharing your story and helping other firefighters understand the importance of early detection.

▶️ Watch Jimmy’s story:
https://youtu.be/LILadHFW6ZE

Most cancers have no recommended routine screening.Today, the U.S. Preventive Services Task Force recommends routine scr...
07/31/2026

Most cancers have no recommended routine screening.
Today, the U.S. Preventive Services Task Force recommends routine screening for only four cancers. Together, they account for less than one-third of all cancer cases.
That means many cancers—including pancreatic, ovarian, liver, kidney, stomach, and esophageal cancer—often have no routine screening option for people without symptoms. Too often, they're discovered only after symptoms appear, when treatment can be more difficult.
That's why we created OneTest for Cancer.
With a simple at-home blood sample, OneTest screens for risk indicators associated with 20+ types of cancer, including many cancers that currently have no recommended routine screening test. It complements—not replaces—recommended screenings such as mammograms and colonoscopies by expanding the cancers you can evaluate.
Your health is one of your most valuable investments. Don't wait for symptoms to start asking questions.
Take a proactive approach to your health with OneTest for Cancer.
👉 Learn more & order today: https://onetestforcancer.com
Source: NORC at the University of Chicago, Cancer Detection Tool – https://cancerdetection.norc.org/ and https://www.norc.org/research/projects/cancer-detection-tool.html. NORC estimates that only four cancers currently have USPSTF-recommended routine screening tests, representing approximately 29% of diagnosed cancers, while cancers without recommended routine screening account for approximately 70% of cancer deaths.
OneTest is not intended to replace physician-recommended cancer screening or medical care. Always consult your healthcare provider regarding your personal health and recommended screenings.

The Risk of Cancer Is Growing. Thankfully, So Is the Science.🤖AI Is Changing Cancer Detection. Why Not Take Advantage of...
07/20/2026

The Risk of Cancer Is Growing. Thankfully, So Is the Science.
🤖AI Is Changing Cancer Detection. Why Not Take Advantage of It?
The World Health Organization (WHO) recently warned that annual cancer cases are expected to rise from 20.6 million to nearly 35 million by 2050. While cancer is becoming more common, the technology available to detect it is evolving faster than ever.
Instead of waiting for symptoms to appear, we now have the opportunity to use artificial intelligence to better understand our cancer likelihood and take action earlier.
At OneTest™ for Cancer, our proprietary AI-powered algorithms analyze 7–12 validated tumor biomarkers and has been trained on data from 10s of thousands of asymptomatic individuals. Rather than evaluating biomarkers one at a time, AI identifies complex patterns that can improve sensitivity and help detect cancer earlier.
📊 The difference AI can make:
• 82.3% sensitivity in men
• 74.8% sensitivity in women
(Research presented through the EDRN/NCI program)
But innovation isn't just making cancer screening smarter—it's making it more convenient.
Today, you can assess your likelihood for 20+ cancer types from the comfort of your home with a simple blood collection device, combining advanced AI-powered analysis with an easy at-home testing experience.
Don’t wait for symptoms to appear.
✅ Screens for 20+ cancer types
✅ AI-powered multi-biomarker analysis
✅ Convenient at-home blood collection
✅ Advanced technology from the comfort of your home
Know your cancer biomarkers. Click the link below to order your OneTest™ for Cancer.

https://onetestforcancer.com/promo/

Cancer Cases Are Expected to Nearly Double by 2050.The latest report from the World Health Organization (WHO) delivers a...
07/10/2026

Cancer Cases Are Expected to Nearly Double by 2050.
The latest report from the World Health Organization (WHO) delivers a powerful reminder that we need to rethink how we approach multicancer risk early detection.
By 2050, the number of new cancer cases worldwide is projected to increase from 20.6 million to nearly 35 million annually. Every day, cancer claims more than 26,000 lives, making it the second leading cause of death globally.
The WHO calls for urgent action, emphasizing the importance of prevention, earlier detection, and improving access to cancer care.
At OneTest, we believe early cancer risk detection should also be more accessible, more convenient, and more affordable.
Instead of focusing on a single type of cancer, OneTest for Cancer is designed to assess the risk of 20+ cancers through a single blood test. With at-home blood collection, FDA-approved biomarkers, and AI-powered analysis, our goal is to make proactive cancer risk assessment easier to access and practical to repeat over time.
As the global burden of cancer continues to grow, innovative approaches to early detection will become increasingly important in helping more people take a proactive role in their health.
The future of cancer care starts with detecting risk earlier.
Read the WHO report: https://www.iarc.who.int/news-events/who-calls-for-urgent-action-as-new-cancer-cases-are-projected-to-nearly-double-by-2050/

What does "accuracy" really mean in a Multi-Cancer Early Detection (MCED) test?Accuracy isn't just a number—it reflects ...
07/07/2026

What does "accuracy" really mean in a Multi-Cancer Early Detection (MCED) test?
Accuracy isn't just a number—it reflects how well a test identifies people with elevated cancer risk while avoiding unnecessary false alarms.
Two measures matter most:
✅ Sensitivity – the ability to correctly identify people with elevated cancer risk. Higher sensitivity means fewer false negatives, reducing the chance that an at-risk person is missed.
✅ Specificity – the ability to correctly identify people who are not at elevated cancer risk. Higher specificity means fewer false positives, reducing unnecessary anxiety and follow-up testing.
This is where AI makes a real difference.
OneTest Proprietary Risk-Prediction AI Algorithm can identify subtle patterns across multiple blood biomarkers that would be difficult to detect through conventional biomarker analysis alone.
At OneTest, we believe innovation should lead to better outcomes—not just more data.
Accuracy. Affordability. Accessibility

Managing your cancer risk is a modern way to gain peace of mind.“Routine cancer screening has proven to be one of the mo...
06/22/2026

Managing your cancer risk is a modern way to gain peace of mind.
“Routine cancer screening has proven to be one of the most effective tools in reducing cancer mortality and improving survival.”
— AACR Cancer Progress Report 2025
That's why OneTest® is committed to making multi-cancer screening more affordable and accessible than ever before. OneTest can be completed from the comfort of your home with a simple blood collection process.
Today, modern tools such as OneTest can help you proactively manage your cancer risk before symptoms appear.
The earlier cancer is found, the easier and less expensive it is to treat.

Address

15810 Gaither Drive, Suite 235
Gaithersburg, MD
20877

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+12404536339

Alerts

Be the first to know and let us send you an email when OneTest for Cancer posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to OneTest for Cancer:

Shortcuts

Share